Planned System Maintenance
Planned System Maintenance
A blood test measuring donor-derived cell-free DNA (dd-cfDNA) is now emerging as a promising tool for earlier detection of transplant complications. The technology enables earlier detection of organ injury and may reduce the need for invasive biopsies, according to the recent publication “Utilizing Cell-Free DNA Technologies for Clinically Significant Biomarkers in Solid Organ Transplantation.”
For the full article click here: Blood Test Tracks Transplant Health Using Donor DNA
Inside, you’ll find the same trusted content, resources, and services as before, now organized in a more intuitive and searchable environment designed to help you get where you need to go faster.
We hope our AI-powered search functionality helps our members get even more from their CAP experience, while strengthening the connections that support our customers every day.
And you can continue to access the eStore, log in using your existing CAP credentials, and access ELSS through the site navigation.
So, take a look around and see what’s changed.
